Cognitive and affective neurorehabilitation
Cognitive and affective disorders resulting from acquired brain injury are frequent and deliberating. These disorders often remain hidden and hence underdiagnosed and undertreated. Concurrently, they pose a risk of prolonged hospitalisation and diminished outcome upon discharge.
When returning to everyday life, those experiencing cognitive and affective disorders face heightened risks of isolation and increased caregiver burden.
The absence of effective and evidence-based neurorehabilitation methods for the cognitive and affective disorders underscores the necessity for focused and fortified research efforts.
Our ultimate goal is to enhance the functional capacity, activity, and participation of patients (and their caregivers), facilitating independence despite the cognitive and affective disorders resulting from acquired brain injuries.
Research Strategy
Our mission is to improve the engagement of research-oriented clinicians and expand our national and international network with fellow researchers in the field. Our ambition is that more research projects should be conducted as multi-centre studies in partnership with our national and international networks.
We aim to recruit more PhD students or postdoctoral researchers in the forthcoming years to further strengthen our research endeavours. We are committed to bolstering our expertise in aphasia and neglect, as well as expanding our broader proficiency in cognitive and affective disorders.
Aphasia and spatial neglect are common cognitive disorders following acquired brain damage, most commonly stroke. Stroke most often occur in the middle cerebral artery, a vital supplier of the perisylvian neural networks within both hemispheres of the brain.
These networks are essential for linguistic and spatial cognitive functions, in the left and right hemisphere respectively, and any damage to them may result in aphasia or spatial neglect in the affected individuals.
Aphasia and spatial neglect both have a profound impact on the patients' independence and caregiver burden. Therefore, the reMIND research group has prioritised the mitigation of these adverse outcomes through targeted and specialised neurorehabilitation research efforts.